source
- Novo Nordisk partners with Amazon Web Services to boost AI-driven drug discovery, opens London hubNovo Nordisk announced a partnership with Amazon Web Services aimed at using artificial intelligence to speed up the discovery of new medicines. The collaboration will see AWS become Novo Nordisk's…
- Sanofi reports shortages of Myozyme and Nexviazyme for Pompe disease after FDA manufacturing warningSanofi has warned that supplies of two medicines used to treat Pompe disease are running low. The company notified patient groups and physicians in the United States and Europe that the shortage af…